Literature DB >> 12185826

Impact of a collaborative pharmacy practice model on the treatment of depression in primary care.

Patrick R Finley1, Heidi R Rens, Joan T Pont, Susan L Gess, Clifton Louie, Scott A Bull, Lisa A Bero.   

Abstract

The effects of a collaborative pharmacy practice model, in which clinical pharmacy specialists provided medication maintenance and follow-up patient care services at a clinic, on patients' adherence to treatment and satisfaction and costs were studied. A cohort of 13 primary care providers (PCPs) was designated to refer patients diagnosed with depression to the practice model at a staff-model health maintenance organization (HMO) immediately after the initiation of antidepressant medications. Clinical pharmacy specialists proceeded to coordinate follow-up with the patients for six months through a combination of scheduled office visits and telephone calls. Working closely with psychiatric liaisons, pharmacists were granted limited prescribing privileges to provide medication comanagement. These patients' adherence to treatment and satisfaction and costs to the HMO were compared with a control group of patients being treated for depression by the remaining 17 PCPs at the facility. A total of 91 patients were referred to the intervention group and received care from the pharmacists during the 10-month enrollment phase; 129 patients were included in the control group. There were no significant differences between groups regarding age, sex and chronic disease scores. An intent-to-treat analysis of medication adherence revealed that adherence was significantly higher in the intervention group (medication possession ratio, 0.81 versus 0.66) (p = 0.0005). Medication switch rates were higher among intervention patients as well (24% versus 5%) (p = 0.0001). There was a greater decline in the number of visits to PCPs for patients in the intervention group (39% versus 12%) (p = 0.029). A collaborative practice model in which clinical pharmacy specialists managed the medication therapy of patients with mild to moderate depression increased patients' adherence to treatment and their satisfaction and reduced the patients' subsequent visits to PCPs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185826     DOI: 10.1093/ajhp/59.16.1518

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  30 in total

1.  Prescribing by pharmacists: information paper (2009).

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-05

2.  Medication management of chronic pain: A comparison of 2 care delivery models.

Authors:  Marlene Slipp; Robert Burnham
Journal:  Can Pharm J (Ott)       Date:  2017-02-08

3.  Evaluating the impact of direct and indirect contact on the mental health stigma of pharmacy students.

Authors:  Elizabeth Nguyen; Timothy F Chen; Claire L O'Reilly
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-07-14       Impact factor: 4.328

4.  Role of a psychiatric pharmacist in a Los Angeles "Skid-Row" safety-net clinic.

Authors:  Indriani Wang; Julie Ann Dopheide; Paul Gregerson
Journal:  J Urban Health       Date:  2011-08       Impact factor: 3.671

5.  Consumer-led mental health education for pharmacy students.

Authors:  Claire L O'Reilly; J Simon Bell; Timothy F Chen
Journal:  Am J Pharm Educ       Date:  2010-11-10       Impact factor: 2.047

6.  Analysis of cost avoidance from pharmacy students' clinical interventions at a psychiatric hospital.

Authors:  Austin R Campbell; Leigh Anne Nelson; Ellie Elliott; Robin Hieber; Roger W Sommi
Journal:  Am J Pharm Educ       Date:  2011-02-10       Impact factor: 2.047

Review 7.  A systematic review and meta-analysis of pharmacist-led fee-for-services medication review.

Authors:  Ernieda Hatah; Rhiannon Braund; June Tordoff; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

8.  Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.

Authors:  Judith E Bosmans; Oscar H Brook; Hein P J van Hout; Martine C de Bruijne; Hugo Nieuwenhuyse; Lex M Bouter; Wim A B Stalman; Maurits W van Tulder
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

9.  Evaluation of a Clinical Pharmacist-Led Multidisciplinary Antidepressant Telemonitoring Service in the Primary Care Setting.

Authors:  Shubha Bhat; Miranda E Kroehl; Katy E Trinkley; Zeta Chow; Lauren J Heath; Sarah J Billups; Danielle F Loeb
Journal:  Popul Health Manag       Date:  2017-12-06       Impact factor: 2.459

10.  Antidepressant adherence after psychiatric hospitalization among VA patients with depression.

Authors:  Kara Zivin; Dara Ganoczy; Paul N Pfeiffer; Erin M Miller; Marcia Valenstein
Journal:  Adm Policy Ment Health       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.